A growing number of hospitals are adopting programs to discuss and fix medical errors.
Alex Olgin
Alex Olgin is a former reporter/producer at Tradeoffs. Prior to her role at Tradeoffs, Alex covered health care for six years at local public radio stations, including working as the sole reporter in Charleston for South Carolina Public Radio and at Gist, producing their healthcare team's daily podcast.
Medical or Recreational? States Debate Where Psychedelics Belong
Amid research on psychedelics to treat mental health conditions, states roll out regulated use.
Ozempic Hype Forces Employer Calls on Obesity Coverage
Employers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
What White House COVID Coordinator Ashish Jha Learned on the Job
During his 14 months as White House COVID Coordinator, Ashish Jha learned about building consensus, crafting practical policy and how to deal with imperfect data.
SCOTUS Weighs Medicaid Recipients’ Right to Sue
A Supreme Court case could change whether Medicaid recipients can continue to use a legal pathway to enforce their rights.
States’ Uphill Battle to Stop Runaway Health Care Costs
Health care prices went from secrets to the subject of public meetings in Massachusetts. Now other states are following suit to bend the cost curve.
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars
More than $50 billion in opioid settlement dollars from drugmakers, distributors and pharmacies are starting to flow to state and local governments.
Medicare’s Prescription Drug Plan Makeover
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
The Push to End Cancer Screening Purgatory
Initial screenings for breast, lung and cervical cancer are free, but expensive secondary tests can leave patients in screening purgatory.
